Who Owns Redcare Pharmacy Company?

Redcare Pharmacy Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns Redcare Pharmacy?

Understanding Redcare Pharmacy's ownership is key to grasping its strategic direction. Its IPO in 2016 was a major turning point, opening it up to public investors.

From its 2001 origins as a Cologne-based pharmacy, Redcare Pharmacy has become Europe's leading online pharmacy. It now serves millions of customers across seven countries, with a significant presence in Germany, Austria, Belgium, Switzerland, and Italy.

The ownership structure of Redcare Pharmacy is diverse, reflecting its public listing. Key stakeholders include institutional investors, public shareholders, and potentially management. For a deeper dive into the company's operational environment, consider a Redcare Pharmacy PESTEL Analysis.

Redcare Pharmacy's origins trace back to 2001 when it began as the online presence for a Cologne-based pharmacy. This venture was spearheaded by a young pharmacist aiming to modernize the family business. While precise initial ownership details and founding member stakes are not extensively documented, Stephan Weber is recognized as a key founder of Shop Apotheke Europe, contributing nearly 25 years of leadership until 2024.

Founding Vision

The initial drive was to create an accessible online pharmacy. This vision was crucial for the company's early growth and expansion into mail-order sales.

Early Legal Landscape

The company's expansion into selling non-prescription medicines via mail order in Germany was facilitated by legal changes in 2004.

Acquisition of Europa Apotheek Venlo

In 2017, Shop Apotheke Europe acquired Europa Apotheek Venlo, a company co-founded by Michael Köhler in 2001.

Public Listing

Michael Köhler played a significant role in the company's public offering in 2016, marking a key milestone in its history.

Stephan Weber's Tenure

Stephan Weber remained a part of the leadership team for approximately 25 years, concluding his tenure in 2024.

Founding Team Expertise

The founding individuals brought a blend of entrepreneurial drive and deep knowledge of the pharmaceutical retail sector.

While specific details regarding early angel investors, initial family and friends' stakes, or any early ownership disputes are not readily available in public records, the foundational vision for an accessible online pharmacy was paramount. Understanding the company's Revenue Streams & Business Model of Redcare Pharmacy provides further context to its early development and ownership structure.

Early Ownership Landscape

The initial ownership structure of Redcare Pharmacy, then known as Shop Apotheke, is not fully detailed publicly. However, key individuals were instrumental in its establishment and growth.

• Stephan Weber was a founder and long-term leader.
• Michael Köhler co-founded Europa Apotheek Venlo, later acquired by the company.
• The company's public listing occurred in 2016.
• The initial focus was on digitalizing traditional pharmacy services.

Redcare Pharmacy SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Redcare Pharmacy's ownership journey began with its public listing in 2016 as Shop Apotheke Europe. This pivotal moment on the Frankfurt Stock Exchange marked a significant shift, leading to its inclusion in indices like the SDAX and later the MDAX. These transitions reflect its growing market presence and influence.

The ownership landscape of Redcare Pharmacy is characterized by a substantial presence of institutional investors, indicating a strong confidence in its market position and future growth. As of July 31, 2025, a significant portion of the company's shares are held by major financial institutions, alongside key strategic investors and private shareholders. This diverse shareholder base influences the company's strategic decisions and its focus on delivering value to its investors, aligning with its Mission, Vision & Core Values of Redcare Pharmacy.

Key Ownership Insights

Redcare Pharmacy's ownership structure is predominantly held by institutional investors, with a notable free float available for public trading.

• The company's market capitalization was $2.18 billion as of August 15, 2025.
• Galenica Ltd. is a significant stakeholder with 10.1% of voting rights and shareholding.
• Institutional investors collectively hold substantial stakes, reflecting broad market confidence.
• The free float represents 82.6% of the company's ownership, allowing for active public trading.

Redcare Pharmacy PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The governance of Redcare Pharmacy is structured with a Managing Board and a Supervisory Board, both composed of individuals appointed by the General Meeting of Shareholders. As of April 2025, the company has issued and outstanding 20,578,391 shares, with each share representing one vote, adhering to a one-share-one-vote principle.

Shareholders holding 3% or more of the company's shares are mandated to disclose this information to the Netherlands Authority for Financial Markets (AFM). The company's shareholder meetings in 2024 and 2025 saw unanimous approval of all agenda items, including board appointments, indicating a generally smooth governance process without reported proxy contests or significant activist interventions that have influenced decision-making.

Shareholder Influence and Voting Power

Redcare Pharmacy operates under a clear one-share-one-vote structure, ensuring that voting power directly correlates with share ownership. This framework is fundamental to understanding who owns Redcare Pharmacy and how decisions are made.

• Each of the 20,578,391 outstanding shares carries one vote.
• Shareholders with holdings of 3% or more must report to the AFM.
• The company has a history of shareholder meetings approving all proposals.
• There have been no public reports of significant governance disputes or activist campaigns.
• Understanding the Brief History of Redcare Pharmacy provides context for its current ownership structure.

Redcare Pharmacy Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Redcare Pharmacy has seen significant shifts in its ownership and strategic direction over the past three to five years. The company rebranded from Shop Apotheke Europe to Redcare Pharmacy in June 2023, signaling a focus on healthcare and international expansion. This period also involved leadership transitions and key acquisitions that have shaped its current ownership landscape.

Institutional investors represent a significant portion of Redcare Pharmacy's shareholder base, as indicated by major shareholder breakdowns in July 2025. While there has been no substantial share dilution in the past year, insider buying was noted in the quarter preceding August 2025, suggesting internal confidence. The company reported a 32% increase in total sales to EUR 2.37 billion for fiscal year 2024, with projections for total sales growth to surpass 25% in fiscal year 2025. The active customer base grew to 13.5 million by H1 2025. Redcare Pharmacy anticipates an adjusted EBITDA margin of 2% to 2.5% for FY 2025, with a long-term target exceeding 8%.

Leadership Evolution

Co-founders transitioned to advisory roles, ensuring continuity. New leadership appointments in CCO and CIO positions were made. Stephan Weber's move to the Supervisory Board provides ongoing founder insight.

Growth and Financial Outlook

Total sales grew by 32% in FY 2024 to EUR 2.37 billion. Projections for FY 2025 anticipate sales growth exceeding 25%. The active customer base reached 13.5 million by H1 2025.

Investor Sentiment and Ownership Trends

Institutional investors are key shareholders. Insider buying indicates positive internal sentiment. The company's Marketing Strategy of Redcare Pharmacy plays a role in its expansion.

Strategic Acquisitions and Integration

The full-year inclusion of MediService boosted prescription sales. These acquisitions are part of the company's strategy to enhance its market position.

Redcare Pharmacy Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔